Alterations in mitochondrial function as a harbinger of cardiomyopathy: Lessons from the dystrophic heart
Open Access
- 22 September 2009
- journal article
- review article
- Published by Elsevier BV in Journal of Molecular and Cellular Cardiology
- Vol. 48 (2), 310-321
- https://doi.org/10.1016/j.yjmcc.2009.09.004
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
- Canadian Institutes of Health Research (77791, 9575)
This publication has 167 references indexed in Scilit:
- Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscleNature Medicine, 2009
- Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophyBritish Journal of Pharmacology, 2008
- PGC-1 coactivators and skeletal muscle adaptations in health and diseaseCurrent Opinion in Genetics & Development, 2008
- Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylationCardiovascular Research, 2008
- Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiencyProceedings of the National Academy of Sciences, 2008
- Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophyNature Medicine, 2008
- Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporinsProceedings of the National Academy of Sciences of the United States of America, 2007
- Cyclosporine A attenuates mitochondrial permeability transition and improves mitochondrial respiratory function in cardiomyocytes isolated from dogs with heart failureJournal of Molecular and Cellular Cardiology, 2007
- The Mitochondrial Production of Reactive Oxygen Species: Mechanisms and Implications in Human PathologyIUBMB Life, 2001
- The mitochondrial permeability transitionBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995